PRMT2 and acute myeloid leukemia: Nevertheless, we do not find any difference between the activated and total form of the studied MAPKs, i.e. SAPK/JNK, ERK1/2, and p38 (Fig. 6c) in the PRMT2KO cells compared to WT AML cells, suggesting that PRMT2 has little to no role to play in these pathways upon LPS stress.